HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long Yu Selected Research

pyramidatine

1/2018Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Long Yu Research Topics

Disease

125Neoplasms (Cancer)
05/2022 - 01/2001
66Hepatocellular Carcinoma (Hepatoma)
07/2021 - 01/2003
17Carcinogenesis
11/2020 - 03/2005
16Neoplasm Metastasis (Metastasis)
11/2022 - 01/2002
15Breast Neoplasms (Breast Cancer)
01/2021 - 07/2010
14Carcinoma (Carcinomatosis)
10/2009 - 01/2002
12Infections
01/2022 - 01/2004
11Liver Neoplasms (Liver Cancer)
01/2019 - 01/2002
7Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 01/2002
6Stomach Neoplasms (Stomach Cancer)
07/2021 - 01/2015
6Stroke (Strokes)
07/2021 - 11/2009
5Hypoxia (Hypoxemia)
07/2021 - 01/2002
4Osteoporosis
12/2021 - 06/2013
4Lung Neoplasms (Lung Cancer)
12/2021 - 02/2013
4Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 09/2009
4Babesiosis (Piroplasmosis)
01/2020 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
09/2017 - 02/2014
4Fibrosis (Cirrhosis)
07/2016 - 04/2003
3COVID-19
03/2022 - 01/2021
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 08/2011
3Osteosarcoma (Osteogenic Sarcoma)
11/2020 - 10/2011
3Adenocarcinoma
01/2018 - 01/2017
3Starvation
05/2013 - 01/2009
2Reperfusion Injury
01/2022 - 01/2021
2Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2021
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 01/2021
2Postmenopausal Osteoporosis
12/2021 - 01/2019
2Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2021 - 01/2021
2Pathologic Processes
12/2020 - 05/2019
2Mouth Neoplasms (Oral Cancer)
01/2018 - 12/2012

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2002
22Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2003
20Messenger RNA (mRNA)IBA
12/2020 - 01/2002
13MicroRNAs (MicroRNA)IBA
05/2022 - 07/2010
9AntigensIBA
12/2021 - 05/2002
9RNA (Ribonucleic Acid)IBA
01/2021 - 03/2005
9DNA (Deoxyribonucleic Acid)IBA
11/2020 - 04/2003
9ORALIT (ORS)IBA
04/2012 - 07/2010
8Pharmaceutical PreparationsIBA
01/2021 - 08/2010
7Monoclonal AntibodiesIBA
12/2021 - 07/2006
7Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
09/2017 - 10/2011
6Long Noncoding RNAIBA
05/2022 - 12/2012
6Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019 - 06/2007
6AntibodiesIBA
01/2019 - 05/2002
6EnzymesIBA
01/2018 - 01/2002
6Complementary DNA (cDNA)IBA
05/2008 - 05/2002
4Phosphotransferases (Kinase)IBA
01/2022 - 02/2010
4Codon (Codons)IBA
12/2020 - 04/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
4Biological ProductsIBA
09/2019 - 11/2011
4IntegrinsIBA
12/2018 - 01/2009
4Aurora KinasesIBA
02/2015 - 03/2010
4Histones (Histone)IBA
01/2015 - 08/2012
4Aurora Kinase BIBA
01/2015 - 08/2012
4Amino AcidsFDA Link
07/2014 - 02/2002
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2014 - 10/2010
4Protein Kinases (Protein Kinase)IBA
12/2013 - 02/2010
4arginylarginine (Arg-Arg)IBA
04/2012 - 09/2010
4CytokinesIBA
02/2012 - 10/2010
3Therapeutic UsesIBA
01/2022 - 02/2012
3Fluorouracil (Carac)FDA LinkGeneric
09/2021 - 01/2018
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2019 - 07/2010
3Small Interfering RNA (siRNA)IBA
01/2018 - 05/2014
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 04/2012
3Caspase 3 (Caspase-3)IBA
01/2017 - 10/2012
3Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2016 - 01/2004
3Carcinoembryonic AntigenIBA
06/2016 - 05/2002
3HLA-DQ Antigens (HLA-DQ)IBA
11/2015 - 01/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 03/2010
3Cyclin D1IBA
01/2015 - 06/2012
3Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2015 - 03/2006
3prolyl-proline (Pro-Pro)IBA
12/2011 - 09/2010
3arginylprolineIBA
12/2011 - 09/2010
3SeptinsIBA
10/2010 - 02/2006
3Matrix Metalloproteinases (MMPs)IBA
07/2010 - 01/2009
2Peptides (Polypeptides)IBA
03/2022 - 05/2011
2Phosphopyruvate Hydratase (Enolase)IBA
12/2021 - 10/2020
2Voltage-Gated Sodium ChannelsIBA
09/2021 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
08/2021 - 07/2017
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2021 - 03/2016
2ElementsIBA
07/2021 - 01/2014
2Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 06/2012
2Immunoglobulin G (IgG)IBA
01/2021 - 05/2008
2GlucocorticoidsIBA
01/2021 - 01/2021
2CyclinsIBA
12/2020 - 01/2020
2RNA-Binding Proteins (RNA-Binding Protein)IBA
12/2020 - 01/2020
2Circular RNAIBA
11/2020 - 01/2019
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2020 - 07/2016
2AflatoxinsIBA
08/2020 - 04/2003
2Indicators and Reagents (Reagents)IBA
01/2020 - 01/2014
2Transforming Growth Factor beta (TGF-beta)IBA
01/2019 - 12/2005
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
12/2018 - 12/2011
2Capsules (Microcapsules)IBA
01/2018 - 07/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 10/2012

Therapy/Procedure

42Therapeutics
01/2022 - 01/2001
6Drug Therapy (Chemotherapy)
01/2021 - 03/2008
6Hepatectomy
11/2020 - 07/2016
3Neoadjuvant Therapy
01/2022 - 01/2019
2Qigong (Qi Gong)
07/2021 - 01/2021
2Activities of Daily Living (ADL)
01/2021 - 03/2020